A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study).
Saved in:
| Title: | A phase II study to determine the ability of gefitinib to reverse fluoropyrimidine resistance in metastatic colorectal cancer (the INFORM study). |
|---|---|
| Authors: | Stebbing, J1, Harrison, M2, Glynne-Jones, R2, Bridgewater, J3, Propper, D4 d.j.propper@qmul.ac.uk |
| Source: | British Journal of Cancer. 2/26/2008, Vol. 98 Issue 4, p716-719. 4p. 3 Charts. |
| Database: | Academic Search Ultimate |
| ISSN: | 00070920 |
|---|---|
| DOI: | 10.1038/sj.bjc.6604232 |
